Codexis Inc (NASDAQ:CDXS) Plummets After Q3 2025 Revenue and Earnings Miss Codexis stock plunges after Q3 2025 earnings miss estimates, with revenue of $8.6M falling far short of expectations.
What's going on in today's after hours session Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Curious about the stocks that are showing activity after the closing bell on Wednesday? After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat Codexis Inc (CDXS) beat Q2 2025 revenue and EPS estimates, driving a 6.89% after-hours stock surge. Strong enzyme engineering and RNAi therapeutic progress fuel optimism.
Get insights into the top gainers and losers of Wednesday's after-hours session. As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024 CDXS stock results show that Codexis missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024 CDXS stock results show that Codexis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
